Status:
RECRUITING
Registry for Invasive and Non-invasive Anatomical Assessment and Outcome of Coronary Artery Anomalies
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Collaborating Sponsors:
University Hospital, Zürich
Conditions:
Anomalous Coronary Artery Origin
Anomalous Coronary Artery Course
Eligibility:
All Genders
18+ years
Brief Summary
An anomalous coronary artery from the opposite sinus of Valsalva (ACAOS) represents a congenital disorder with an anomalous location and/or course of the coronary vessel. The prevalence of ACAOS in th...
Detailed Description
Anomalous coronary arteries (CAA) represent a congenital disorder hallmarked by an anomalous location of the coronary ostium and/or vessel course. Based on the largest study assessing the prevalence a...
Eligibility Criteria
Inclusion
- Age ≥18 years.
- CAA with a clinically indicated testing (noninvasive and/or invasive measurement) at our institution
- Informed consent
Exclusion
- \- None
Key Trial Info
Start Date :
January 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2030
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04475289
Start Date
January 1 2000
End Date
June 30 2030
Last Update
May 14 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Inselspital, Bern
Bern, Switzerland, 3010
2
University Hospital, Zürich
Zurich, Switzerland